Cataract & Refractive 360: Focus on Advances in Cataract Surgery - Volume 5, Number 1
This activity is supported by educational grants from Alcon Vision, LLC; Bausch + Lomb; Carl Zeiss Meditec, Inc.; J&J Vision; and STAAR Surgical.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by educational grants from Alcon Vision, LLC; Bausch + Lomb; Carl Zeiss Meditec, Inc.; J&J Vision; and STAAR Surgical.
Activity Description
Evolving technologies and refined techniques for cataract and refractive surgery continue to develop, increasing the number of options for improving visual acuity and enhancing patient quality of life. Successful cataract and refractive surgery rely on an interprofessional team, each playing a role in the multifactorial process, from preoperative assessment to postoperative care. Of the many vision-correction techniques available, selection can be challenging and must take into consideration patient preferences, characteristics, and expectations. In this CE monograph, experts in the field evaluate advances in presurgical/surgical diagnostics and intraoperative guidance systems; assess cataract workflow systems that can aid in screening, planning, lens selection, and patient communication; summarize advances in biometry as well as intraocular lens calculations and platforms; and review interprofessional approaches to care that can improve efficiency and overall outcomes for patients undergoing cataract refractive procedures.
Target Audience
The intended audience for this activity is ophthalmologists, optometrists, and other health care professionals involved in the management of patients undergoing cataract and/or refractive surgery.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Evaluate advances in presurgical/surgical diagnostics and intraoperative guidance systems and their impact on improved refractive outcomes.
- Assess cataract workflow systems that can aid in screening, planning, lens selection, and patient communication.
- Explore the latest information on phacoemulsification, including the use of fluidics, ultrasound, phacodynamics, advanced techniques, and instrumentation.
- Examine the latest information pertaining to the digital integration of medical and surgical eye care.
- Investigate the evaluation and management techniques necessary to optimize cataract surgery outcomes in complex cases.
- Explore diagnostic and surgical techniques that can be used to correct astigmatism before, during, and after cataract removal.
- Summarize advances in biometry as well as intraocular lens calculations and platforms.
- Describe interprofessional approaches to care that can improve efficiency and overall outcomes for patients undergoing cataract refractive procedures.
Activity Chair
Elizabeth Yeu, MD
Cornea, Cataract, External Disease and Refractive Surgery
Virginia Eye Consultants/EyeCare Partners
Assistant Professor, Eastern Virginia Medical School
President, American Society of Cataract and Refractive Surgery (ASCRS)
Norfolk, VA
Faculty
Douglas Devries, OD
Clinic and Residency Director
Associate Clinical Professor of Optometry
Pacific University
Co-Founder, Eye Care Associates of Nevada
Sparks, NV
Eric D. Donnenfeld, MD
Ophthalmic Consultants of Long Island
Clinical Professor of Ophthalmology
New York University
Trustee, Dartmouth Medical School
New York, NY
Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea Division
Director, Refractive Surgery Service
Duke University Eye Center
Durham, NC
Karolinne Maia Rocha, MD, PhD
Director Cornea & Refractive Surgery
Associate Professor of Ophthalmology
Cornea & Refractive Fellowship Director
Mount Pleasant, SC
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Walter O. Whitley, OD, MBA, FAAO
Medical Writer
Valerie Zimmerman, PhD
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education designates this enduring activity for a maximum of 1.0 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
COPE Course Number: 89914-POCOPE Activity Number: 127837
This enduring material is approved for 1 year from the date of original release, February 29, 2024, to February 28, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate or COPE CE Certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
The articles in this monograph were composed by medical writer Valerie Zimmerman, PhD, based on the presentations of Drs. Devries, Donnenfeld, Rocha, Kim, and Yeu based on a live webinar presentation held on November 18, 2023. The monograph has been approved by each of the faculty individually as an accurate representation of their presentations.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Elizabeth Yeu, MD
Consultant: AcuFocus, Adaptilens, Advanced Vision, Aldeyra, Allergan, Aurion, Avellino, Bausch + Lomb, BioTissue, BlephEx, Bruder, BVI, Centricity, CorneaGen, Dompé, Elios, Expert Opinion, Eyenovia, Foresight, Glaukos, Guidepoint, Iveric Bio, Johnson & Johnson Vision, Kala, LayerBio, Lensar, Melt, Merck, New World Medical, Novartis, Ocular Science, OCuSOFT, Samsara, ScienceBased Health, Sight Sciences, STAAR, Surface, Tarsus, Théa, Visus, Zeiss
Speaker Contracted by Ineligible Company: Alcon
Independent Research Contractor: AcuFocus, Alcon, BioTissue, New World Medical, Ocular Science, Tarsus
Individual Stocks and Stock Options (publicly traded): STAAR, Tarsus
*Individual Stocks and Stock Options (privately held): Aurion
Douglas Devries, OD
Advisor: Allergan, Alcon, Asecula, Avellino, Azura, BioTissue, Bruder, Bausch + Lomb, Dompe, Harrow, Johnson and Johnson, Kala, Lumenis, Neurolens, Novaliq,Novartis, OCuSOFT, Ocuphire, Ophthalmic Resources Partners, Orasis, Oyster Point, QuidelOrtho,
RVL Pharma, Science Based Health, Sight Sciences, Sun, Tarsus, Thea, Trukera Medical, Verséa, Visus
Speaker Contracted by Ineligible Company: Alcon, BioTissue, Bausch + Lomb, Dompe, Johnson and Johnson, Kala, Lumenis, Novartis, Oyster Point, RVL Pharma, RxSight, Science Based Health, Sight
Eric D. Donnenfeld, MD
Consultant: Aeon, Alcon, Allegro, Allergan, Amring, Aurion, Avellino, Bausch + Lomb, BlephEx, BVI, CorneaGen, Covalent, CRST, Crystilex, Dompé , ELT Sight, EyePoint, Foresight, Glaukos, Horizon Surgical, Ivantis, Johnson & Johnson Vision, Kala, Katena, LacriPen, LayerBio, LensGen, Mati Pharmaceuticals, MDbackline, Melt, Merck, Mimetogen, Nanowafer, NovaBay, Novaliq, Novartis, Ocular Innovations, OcuHub, Oculis, Odyssey, Omega Ophthalmics, Omeros, Oyster Point, Pfizer, PogoTec, Physician Recommended Neutriceuticals, Rayner, ReTear, RPS, Shire, Strathspey Crown, Sun, Surface, Tarsus, TearScience, Thea, Veracity, Versant Ventures, Visionary Ventures, Visus, Zeiss
Individual Stocks and Stock Options (publicly traded): Aeon, Aurion, Avedro, EyePoint, Glaukos, NovaBay, Oculis, Tarsus
*Individual Stocks and Stock Options (privately held): CorneaGen, Covalent, Crystilex, ELT Sight, Horizon Surgical, Ivantis, LacriPen, LayerBio, LensGen, Mati Therapeutics, MDbackline, Melt, Mimetogen, OcuHub, Ocular Innovations, Orasis, PogoTec, Rayner, ReTear, RPS, Strathspey Crown, Surface, Veracity, Versant Ventures, Visionary Ventures, Visus
Terry Kim, MD
Consultant: Adaptilens, Alcon, Aurion Biotech, Avellino, Azura Ophthalmics, Bausch + Lomb, BVI, Clearview Healthcare Partners, CorneaGen, Dermavant, Eluminex, Euclid Vision Group, Expert Opinion, Eyenovia, Glaukos, Harrow Health, Iveric Bio, Johnson & Johnson Vision, Kala, Kriya, LENZ Therapeutics, Lexitas, Melt Pharmaceuticals, Oyster Point, Santen, Sight Sciences, Surface, Tarsus, Thea, Visionology, Zeiss
Individual Stock & Stock Options (publicly traded): Kala, Ocular Therapeutix, Omeros
*Individual Stock & Stock Options (privately held): Adaptilens, Aurion Biotech, Avellino, CorneaGen, Euclid Vision Group, Eyenovia, LENZ Therapeutics, Lexitas, Melt Pharmaceuticals, Simple Contacts, Surface
Karolinne Maia Rocha, MD, PhD
Consultant: Bausch + Lomb, Johnson & Johnson Vison, Staar, Zeiss
*Does not discuss business lines or products of the companies.
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Walter O. Whitley, OD, MBA, FAAO
Consultant: Alcon, Aldeyra, Allergan, Azura, Bausch + Lomb, Bruder, Dompé, Heru, Iveric Bio, Kala, Lumenis, Ocuphire, Oyster Point, ScienceBased Health, Sight Sciences, Sun, Tarsus, Thea Pharma, Visus, Zeiss
Speaker Contracted by Ineligible Company:
Alcon, Allergan, Bausch + Lomb, Dompé, Kala, Oyster Point, Sun, Tarsus
Medical Writer reports the following relevant financial relationship(s)
Valerie Zimmerman, PhD
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). To do so, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com